Free Trial

3 Underperforming Nasdaq 100 Stocks Worth a Closer Look

Key Points

  • The strategy of rotating to the Nasdaq’s biggest laggards is far from foolproof, but it makes good sense.
  • Despite being down more than 40% year-to-date, analysts still have faith in Enphase Energy.
  • Moderna’s mRNA pipeline includes 45 vaccine and therapeutic candidates.
  • The company also announced a partnership with IBM to explore the use of generative AI and quantum computing in mRNA science.
  • With a consensus price target that implies nearly 80% upside, Zscaler could be one of the Nasdaq-100’s biggest comeback stories of 2023-2024.
  • MarketBeat previews the top five stocks to own by February 1st.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Enphase Energy Right Now?

Before you consider Enphase Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enphase Energy wasn't on the list.

While Enphase Energy currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Enphase Energy (ENPH)
4.4673 of 5 stars
$62.24-2.7%N/A141.45Hold$93.43
Moderna (MRNA)
4.6868 of 5 stars
$44.94+7.9%N/A-7.72Hold$69.79
Zscaler (ZS)
4.4915 of 5 stars
$204.68+7.0%N/A-818.72Moderate Buy$225.47
Verizon Communications (VZ)
4.9677 of 5 stars
$40.44-0.5%6.70%17.43Hold$46.44
Intel (INTC)
4.5774 of 5 stars
$19.80-2.4%N/A-5.32Reduce$27.88
PDD (PDD)
4.7785 of 5 stars
$112.18+1.2%N/A10.96Moderate Buy$173.40
T-Mobile US (TMUS)
4.9264 of 5 stars
$221.16-0.1%1.59%25.22Moderate Buy$245.74
Activision Blizzard (ATVI)
1.2145 of 5 stars
$94.42flat1.05%34.59N/AN/A
Meta Platforms (META)
4.3597 of 5 stars
$674.33+2.2%0.30%31.76Moderate Buy$654.20
Tesla (TSLA)
4.8137 of 5 stars
$398.31+0.3%N/A109.13Hold$313.84
Align Technology (ALGN)
4.6864 of 5 stars
$226.17-1.6%N/A38.60Moderate Buy$267.45
Merck & Co., Inc. (MRK)
5 of 5 stars
$97.49-0.5%3.32%20.44Moderate Buy$122.67
International Business Machines (IBM)
4.6922 of 5 stars
$225.34+0.5%2.96%32.80Hold$220.40
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

7 Stocks to Benefit From Trump’s Tariffs in 2025

7 Stocks to Benefit From Trump’s Tariffs in 2025

While the impact of these tariffs remains uncertain, some stocks are positioned to thrive under these policies; check out these 7 stock picks now.

Recent Videos

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025
Pelosi Bets Big on AI: Her Top 5 Stock Picks
Risk vs. Reward: Why Analysts Predict Big Gains for Struggling SMCI

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines